First hepatitis C treatment approved for co-infected patients.
In February 2005, the FDA FDA
abbr.
Food and Drug Administration
FDA,
n.pr See Food and Drug Administration.
FDA,
n.pr the abbreviation for the Food and Drug Administration. approved the combination of Pegasys
(peg-Interferon) and Copegus (ribavirin) for the treatment of hepatitis
C virus - This page is for the virus. For the disease, see Hepatitis C.
The Hepatitis C virus (HCV) is a small (50 nm in size), enveloped, single-stranded, positive sense RNA virus in the family Flaviviridae. (HCV HCV
abbr.
hepatitis C virus
HCV 1 Hepatitis C virus, see there 2. Human coronavirus. See Coronavirus. ) in HIV+ patients. This treatment is the first one approved
for patients co-infected with HIV and HCV. Also, patients taking Pegasys
in combination with nucleoside reverse transcriptase inhibitors
("nukes") should be monitored closely for side effects,
particularly liver problems.
COPYRIGHT 2005 The Center for AIDS: Hope & Remembrance Project
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion